# LORAZEPAM

NDC: 71610-229
Generic name: LORAZEPAM
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20170324

FDA application: ANDA203572

## Active ingredients

- LORAZEPAM: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-229"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-229
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=247110f2-5468-4593-8d86-41f8c869e03d
